Taisho Pharmaceutical Holdings Analysis

Taisho Pink Sheet Analysis Notes

The company has price-to-book ratio of 0.57. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Taisho Pharmaceutical last dividend was issued on the 29th of September 2022. Taisho Pharmaceutical Holdings Co., Ltd., through its subsidiaries, researches, develops, manufactures, markets, distributes, and sells over-the-counter drugs and prescription pharmaceutical products in Japan and internationally. Taisho Pharmaceutical Holdings Co., Ltd. was founded in 1912 and is headquartered in Tokyo, Japan. Taisho Pharmaceutical operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 9134 people.The quote for Taisho Pharmaceutical Holdings is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Taisho Pharmaceutical Holdings contact the company at 81 3 3985 2020 or learn more at https://www.taisho-holdings.co.jp.

Taisho Pharmaceutical Investment Alerts

Taisho Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.35 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Taisho Pharmaceutical's market, we take the total number of its shares issued and multiply it by Taisho Pharmaceutical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Taisho Profitablity

The company has Profit Margin (PM) of 0.08 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.09 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.09.

Taisho Pharmaceutical Predictive Daily Indicators

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Taisho Pharmaceutical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Taisho shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Taisho Pharmaceutical. By using and applying Taisho Pink Sheet analysis, traders can create a robust methodology for identifying Taisho entry and exit points for their positions.

Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

If you are still planning to invest in Taisho Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taisho Pharmaceutical's history and understand the potential risks before investing.